Immediate Impact

58 standout
Sub-graph 1 of 23

Citing Papers

A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
2024 Standout
Mapping the single-cell transcriptomic response of murine diabetic kidney disease to therapies
2022 Standout
5 intermediate papers

Works of Henrik Hadimeri being referenced

Increased risk of renal biopsy complications in patients with IgA-nephritis
2015
Risk factors for the development of albuminuria and renal impairment in type 2 diabetes--the Swedish National Diabetes Register (NDR)
2010

Author Peers

Author Last Decade Papers Cites
Henrik Hadimeri 321 148 126 31 544
Mauer Sm 165 87 144 28 510
Gurland Hj 210 91 125 38 562
Yener Koç 259 59 87 50 468
Theodore J. Buselmeier 160 110 202 22 569
Alper Kırkpantur 238 94 109 34 564
Emel Akoğlu 184 93 232 28 639
Ramesh Naik 266 108 159 29 530
Nayara Panizo 256 121 171 42 562
Patrocinio Rodríguez Benítez 324 73 115 27 480
Ana Rocha 160 66 190 41 599

All Works

Loading papers...

Rankless by CCL
2026